European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Date of authorisation: 04/12/2016, Revision: 23, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2026 - 15:20

Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Date of authorisation: 04/12/2016, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 18, Status: Withdrawn

Submitted by Anonymous (not verified) on 10 July 2026 - 15:18

Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Date of authorisation: 24/04/2017, Revision: 18, Status: Withdrawn

Human medicines European public assessment report (EPAR): Fendrix, hepatitis B (rDNA) vaccine (adjuvanted, adsorbed), Date of authorisation: 02/02/2005, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2026 - 15:08

Human medicines European public assessment report (EPAR): Fendrix, hepatitis B (rDNA) vaccine (adjuvanted, adsorbed), Date of authorisation: 02/02/2005, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 28/02/2011, Revision: 38, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2026 - 15:02

Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 28/02/2011, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Date of authorisation: 16/03/2016, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2026 - 14:51

Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Date of authorisation: 16/03/2016, Revision: 15, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness